CAR-T Cells and the Kidney: Insights from the WHO Safety Database

BACKGROUND: Chimeric antigen receptor T (CAR-T) cells have proven to be a game changer for treating several hematologic malignancies. Randomized controlled trials have highlighted potential life-threatening adverse drug reactions (ADRs), including cytokine release syndrome (CRS). Acute renal failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Gérard, Alexandre O., Merino, Diane, Charbinat, Alexis, Fournier, Joseph, Destere, Alexandre, Loschi, Michael, Cluzeau, Thomas, Sicard, Antoine, Drici, Milou-Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287817/
https://www.ncbi.nlm.nih.gov/pubmed/37166707
http://dx.doi.org/10.1007/s40259-023-00599-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287817/
https://www.ncbi.nlm.nih.gov/pubmed/37166707
http://dx.doi.org/10.1007/s40259-023-00599-1

Ejemplares similares